Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
Work
Year: 2021
Type: article
Abstract: Purpose: We assessed whether perioperative circulating tumor DNA (ctDNA) could be a biomarker for early detection of molecular residual disease (MRD) and prediction of postoperative relapse in resect... more
Source: Clinical Cancer Research
Cites: 39
Cited by: 177
Related to: 10
FWCI: 16.24
Citation percentile (by year/subfield): 99.99
Subfield: Cancer Research
Domain: Life Sciences
Sustainable Development Goal Good health and well-being
Open Access status: green
Grant IDS ZYGD18021, ZYJC18009